术中用的S-氯胺酮,还影响一年后......
摘要译文
术中使用S-氯胺酮降低脊柱手术后一年阿片类药物消耗量并减轻疼痛程度:一项针对阿片类依赖患者的随机临床试验
1背景:
我们的目的是探讨术中使用S-氯胺酮对接受脊柱融合术的慢性阿片依赖患者术后1年的镇痛药消耗和疼痛的影响。
2方法:
单中心、随机、盲法试验、共147例病例。
3干预:
围手术期给予S-氯胺酮负荷剂量0.5mg/kg,然后给予S-氯胺酮0.25mg/kg/hr或安慰剂。
4主要结局:
通过书面问卷调查评估术后一年的镇痛药使用量、疼痛程度(视觉模拟量表0-100 mm[VAS])和劳动力市场依恋度。
5结果:
随访回应率为67%。术后一年中:
▶氯胺酮组与安慰剂组相比,每日口服吗啡等效物的用量较低:0(0-20)mg与20(0-62)mg,(p=0.02)。
▶氯胺酮组与安慰剂组相比,每日使用任何一种镇痛药的患者比例较少,分别为42%(95%CI 23-61)与74%(95%CI 58-87),(p=0.04)。
▶与安慰剂组相比,氯胺酮组的活动性疼痛更低:中位数差异为17 mm(95%CI:-30至-3),(p=0.02)。
▶与安慰剂组相比,氯胺酮组的静息痛更低,中位数差异为13mm(95%CI:-23至-3),(p=0.01)。
▶氯胺酮组的劳动力市场依恋度更好(p=0.02)。
6结论:
在慢性阿片类药物依赖人群中,术中使用氯胺酮可减少术后1年的镇痛药使用量,减轻疼痛,改善劳动力市场依恋度。
7意义:
这项随机临床试验表明,术中使用氯胺酮可减少阿片类药物的使用量和减轻疼痛程度,并改善阿片类药物依赖人群脊柱手术后一年的劳动力市场依恋度。
原文摘要
IntraoperativeS-ketamine for the reduction of opioid consumption and pain one year afterspine surgery: A randomized clinical trial of opioid-dependent patients
Background: Weaimed to explore the effect of intraoperative S-ketamine on analgesicconsumption and pain one year after spine surgery in chronic opioid-dependentpatients undergoing spinal fusion surgery.
Methods: Single-centre,randomized, blinded trial of 147 patients.
Intervention: PerioperativeS-ketamine bolus 0.5 mg/kg followed by S-ketamine 0.25 mg kg-1 hr-1 infusionor placebo.
Main outcomes: Analgesicuse, pain (visual analogue scale 0-100 mm [VAS]) and labour market attachmentone year after surgery assessed by written questionnaires.
Results: Responserate was 67%. One year after surgery, the daily use of oral morphineequivalents was lower in the ketamine group versus the placebo group: 0 (0-20)mg versus 20 (0-62) mg, (p = 0.02), and fewer patients had a daily use of anyanalgesics in the ketamine group versus placebo group, 42% (95% CI 23-61)versus 74% (95% CI 58-87), (p = 0.04). Mobilization pain was lower in theketamine group compared to the placebo group: Median difference 17 mm (95% CI-30 to -3), (p = 0.02). Pain at rest was lower in the ketamine group comparedto the placebo group with median difference: 13 mm (95% CI -23 to -3), (p =0.01). Further, labour market attachment was better in the ketamine group, (p =0.02).
Conclusion: Intraoperativeketamine may reduce analgesic use, pain, and improve labour market attachmentone year after spine surgery in a chronic opioid-dependent population.
Significance: Thisrandomized clinical trial shows that intraoperative ketamine may reduce opioiduse and pain and improve labour market attachment one year after spine surgeryin an opioid-dependent population.
不感兴趣
看过了
取消
不感兴趣
看过了
取消
精彩评论
相关阅读